Operating Income: The income after operating expenses.
AngioDynamics, Inc. (ANGO) had Operating Income of $-39.93M for the most recently reported fiscal year, ending 2026-05-31.
| Income Statement Financials | |
$320.17M |
|
$-36.74M |
|
$145.28M |
|
$174.89M |
|
$360.10M |
|
|
Operating Income |
$-39.93M |
$3.63M |
|
$-36.30M |
|
$-36.30M |
|
$-36.74M |
|
$-36.74M |
|
$-36.74M |
|
$-36.74M |
|
$-39.93M |
|
$-16.97M |
|
41.53M |
|
41.53M |
|
$-0.88 |
|
$-0.88 |
|
| Balance Sheet Financials | |
$163.39M |
|
$27.10M |
|
$103.77M |
|
$267.16M |
|
$74.72M |
|
-- |
|
$21.62M |
|
$96.34M |
|
$170.82M |
|
$103.62M |
|
$170.82M |
|
41.70M |
|
| Cash Flow Statement Financials | |
$3.09M |
|
$-5.95M |
|
$0.56M |
|
$55.89M |
|
$53.86M |
|
$-2.03M |
|
$13.96M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.19 |
|
-- |
|
-- |
|
-- |
|
-- |
|
54.62% |
|
-12.47% |
|
-12.47% |
|
-5.30% |
|
-11.34% |
|
-11.48% |
|
$0.51M |
|
-- |
|
-- |
|
-- |
|
1.20 |
|
2.77 |
|
6.63 |
|
55.09 |
|
-21.51% |
|
-35.46% |
|
-13.75% |
|
-21.51% |
|
$4.10 |
|
$0.01 |
|
$0.07 |
|